Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
Huvudupphovsmän: | Flossmann, O, Jones, R, Jayne, DR, Luqmani, R |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
2006
|
Liknande verk
Liknande verk
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
av: Mukhtyar, C, et al.
Publicerad: (2006) -
Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
av: Mukhtyar, C, et al.
Publicerad: (2008) -
Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
av: Saket Jha, et al.
Publicerad: (2019-01-01) -
Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
av: Zhi-Ying Li, et al.
Publicerad: (2020-08-01) -
A Case of Postcoronavirus Disease 2019 Antineutrophil Cytoplasmic Antibody-associated Vasculitis Successfully Treated with Rituximab
av: Mahmoud M. Mohamed, et al.
Publicerad: (2023-07-01)